MEOX1 and non-small cell lung carcinoma: In vitro and in vivo functional experiments have demonstrated that stable overexpression of MEOX1 significantly inhibits the proliferative capacity of NSCLC cells, induces cell cycle arrest in the G2 phase, and enhances apoptotic capabilities.